What are the recommended prescription medications for motion sickness available in Canada?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Motion Sickness Medications Available in Canada by Prescription

Transdermal scopolamine (Transderm-V) is the most effective prescription medication for motion sickness prevention available in Canada, with clinical studies showing 60-80% reduction in motion sickness symptoms compared to placebo. 1

First-Line Therapy: Scopolamine

Transdermal Scopolamine

  • Formulation: Transdermal patch delivering approximately 1 mg over 3 days 2
  • Dosing: Apply one patch to hairless area behind ear at least 4-6 hours before travel (ideally 8-12 hours for optimal effect) 2, 3
  • Duration: Effective for up to 3 days; for longer trips, remove and apply new patch behind opposite ear 2
  • Mechanism: Anticholinergic that blocks muscarinic receptors in the vestibular apparatus and vomiting center
  • Efficacy: 60-80% reduction in motion sickness incidence and severity compared to placebo 3

Clinical Considerations for Scopolamine

  • Advantages:

    • Longer duration of action (72 hours) compared to oral medications
    • Lower incidence of sedation compared to antihistamines 3
    • Steady drug delivery avoids peaks and troughs of oral dosing
    • Protective plasma concentration (50 pg/mL) achieved after 6 hours 3
  • Contraindications: 2

    • Angle-closure glaucoma
    • Hypersensitivity to scopolamine or belladonna alkaloids
  • Common Side Effects: 2, 3

    • Dry mouth (50-60% of users)
    • Drowsiness (up to 20%)
    • Blurred vision (transient)
    • Contact dermatitis at application site (10%)
  • Serious Adverse Effects (rare): 2

    • Acute angle-closure glaucoma
    • Neuropsychiatric reactions (confusion, hallucinations)
    • Seizures (in predisposed individuals)

Second-Line Therapies

First-Generation Antihistamines

  • Dimenhydrinate (Gravol):

    • Dosing: 50-100 mg every 4-6 hours (max 400 mg/day) 4
    • Efficacy: Less effective than scopolamine but superior to placebo 4, 5
    • Side Effects: Higher incidence of sedation compared to scopolamine 3
  • Promethazine:

    • Dosing: 12.5-25 mg orally or rectally every 4-6 hours 6
    • Side Effects: CNS depression, anticholinergic effects, extrapyramidal symptoms 6

Combination Therapy

For severe cases or when single agents are ineffective:

  • Scopolamine + Antihistamine: May provide enhanced efficacy but with increased risk of side effects
  • Scopolamine + Oral Scopolamine: For faster onset (apply patch + 0.3-0.6 mg oral dose 1 hour before travel) 3

Patient Selection Algorithm

  1. For long journeys (>6 hours) or when oral therapy is ineffective:

    • Transdermal scopolamine (first-line)
  2. For shorter journeys or patients with contraindications to scopolamine:

    • First-generation antihistamines (dimenhydrinate, promethazine)
  3. For patients with history of severe motion sickness:

    • Consider combination therapy
  4. For patients with glaucoma, prostatic hypertrophy, or cognitive concerns:

    • Avoid scopolamine; use antihistamines with caution

Important Clinical Pearls

  • Apply scopolamine patch at least 4-6 hours before travel (ideally 8-12 hours for optimal effect) 3
  • Wash hands thoroughly after application to avoid transferring medication to eyes 2
  • Approximately 20-30% of patients may not achieve protective plasma concentrations with transdermal scopolamine 3
  • Nonsedating antihistamines, ondansetron, and ginger root are not effective for motion sickness prevention 7
  • Elderly patients and children are more sensitive to neurological and psychiatric effects of scopolamine 2
  • For patients requiring rapid onset protection, consider combination of transdermal patch plus oral medication 3

Transdermal scopolamine remains the gold standard prescription medication for motion sickness prevention in Canada, offering superior efficacy with a favorable side effect profile compared to other available options 3, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.